Biotech Fininance 2022

Biotech Showcase returning to San Francisco

By The Science Advisory Board staff writers

November 18, 2021 -- The 14th annual Biotech Showcase will be held in person in San Francisco January 10-12, 2022, and virtually January 17-19, 2022, according to organizers Demy-Colton and the EBD Group.

The program will feature insights from top investors and biopharma executives covering topics such as:

  • How the biopharma industry can accelerate drug discovery and manufacturing to prepare for future pandemics
  • Updates in therapeutic areas such as oncology, clinical neurosciences, cell and gene therapy, and rare diseases
  • How COVID-19 accelerated an adoption of all things digital

Company presentations and select on-demand content will be released up to five weeks prior to the event.

Last year's virtual event included 2,500 attendees, with more than 300 company presentations and 850 investors, the organizers said.

Beyond capital -- what it takes for biopharma startups to succeed
Investors are more interested in the biopharmaceutical sector than ever before. But success for biopharma startups means more than just securing investment...
Development 'cookbooks' could speed up gene therapy
Great strides have been made in the development of gene editing tools in the past decade, but translating the technology into real therapies to treat...
What makes immuno-oncology therapies attractive investments?
Although immuno-oncology therapies have been around for many years, investors are excited to partner with innovators in the space who can push the boundaries...

Copyright © 2021

HPLC 2022
June 18-23
San Diego, California United States
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter